Pharmacokinetics, Safety, and Efficacy of ARQ-151 Once a Day in Adolescents and Children With Mild to Moderate Eczema

Condition:   Atopic Dermatitis (Eczema) Intervention:   Drug: ARQ-151 cream 0.15% Sponsor:   Arcutis, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials